[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368804-105":59,"doc-detail-368804-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pretransplant-screening-and-lower-incidence-of-breast-and-prostate-cancers-among-organ-transplant-recipients-in-the-united-states-brief-communications","Pretransplant screening and lower incidence of breast and prostate cancers among organ transplant recipients in the United States - Brief Communications","","Solid organ transplant recipients (SOTRs) in the United States show lower risks for breast and prostate cancers than the general population. A case-control analysis of US adults aged 65+ using the SEER-Medicare database (2000–2019) tested whether pretransplant screening explains this pattern. Among 252,279 breast cancer cases and matched controls, and 316,981 prostate cancer cases and controls, screening with mammography or PSA was linked to reduced cancer odds, suggesting screening likely accounts for much of the deficit, with additional protective factors possibly contributing.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pretransplant-screening-and-lower-incidence-of-breast-and-prostate-cancers-among-organ-transplant-recipients-in-the-united-states-brief-communications/368804/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pretransplant-screening-and-lower-incidence-of-breast-and-prostate-cancers-among-organ-transplant-recipients-in-the-united-states-brief-communications/368804.png","ImageObject",300,407,{"name":92,"@type":93},"Aran","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does the study address about US organ transplant recipients?","Question",{"text":112,"@type":113},"It examines whether pretransplant cancer screening explains why US solid organ transplant recipients have lower breast and prostate cancer incidence than the general population.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What data and timeframe were used for the case-control study?",{"text":117,"@type":113},"The study used SEER-Medicare linkage data for adults aged 65 years or older, covering diagnoses from 2000 to 2019.",{"name":119,"@type":110,"acceptedAnswer":120},"How were screening and transplant status captured in the analysis?",{"text":121,"@type":113},"Medicare claims identified solid organ transplant procedures, and screening was determined using mammography or prostate-specific antigen testing before case/control selection.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368804,1790799084,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":19,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":52,"preview_page_count":19,"preview_urls":144},137455076865,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","JNCI Cancer Spectrum, 2025, 9(5), pkaf080  \n[https://doi.org/10.1093/jncics/pkaf080](https://doi.org/10.1093/jncics/pkaf080)  \nAdvance Access Publication Date: August 7, 2025  \nBrief Communications  \nPretransplant screening and lower incidence of breast and prostate cancers among organ transplant recipientsin the United States  \nShyfuddin Ahmed , PhD􀀃 ,1, Michael J. Silverberg , PhD2, Eric A. Engels , MD1 1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20892, United States 2Division of Research, Kaiser Permanente Northern California, Pleasanton, CA 94588, United States  \n􀀃 Corresponding author: Shyfuddin Ahmed, PhD, Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Drive, Rockville, MD 20892, United States ([shyfuddin.ahmed@nih.gov](shyfuddin.ahmed@nih.gov)) .  \nAbstract  \nSolid organ transplant recipients (SOTRs) in the United States have lower risks for breast and prostate cancers than the general population. To explore whether pretransplant screening explains this observation, we conducted a case-control study of US adults aged 65 years or older using the SEER-Medicare database (2000-2019) . We included 252 279 breast cancer cases, 3 855 275 female controls, 316 981 prostate cancer cases, and 2 361 846 male controls. We used Medicare claims to identify solid organ transplant proceduresand screening with mammography or prostate-specific antigen testing before case/control selection. SOTRs exhibited reduced risks for breast cancer (adjusted odds ratio ¼ 0.60, 95% CI ¼ 0.45 to 0.80) and prostate cancer (0.84, 95% CI ¼ 0.71 to 1.00) . These inverse associations were significant among screened individuals, although a borderline association for breast cancer was suggested in unscreened women. Pretransplant cancer screening probably largely explains the reduced risks of breast and prostate cancer among US SOTRs, but there may also be other protective factors.  \nSolid organ transplant recipients (SOTRs) have an increased overall risk of cancer compared with the general population.1 SOTRs are treated with immunosuppressive medications to prevent rejection of their transplanted organ,2 which decreases immunosurveillance and contributes to the high cancer incidence.3 For unknown reasons, SOTRs in the United States experience a lower incidence of breast and prostate cancers than the general population,1 ,4 whereas SOTRs in other countries exhibit no change in risk for these cancers.5-9 The deficit of breast and prostate cancers seen in US SOTRs is present for all age groups combined1 and, specifically, among SOTRs older than age 65 (Table S1) .  \nTransplant candidates undergo pretransplant cancer screening due to concern that immunosuppression could increase the aggressiveness of an undiagnosed cancer.10 In addition, transplanted organs are a scarce resource, so it is important to rule out or treat comorbid medical conditions such as cancer, to ensure the organs are given to people who will most benefit.11 Consensus recommendations suggest a waiting period before considering transplantation for individuals with a new diagnosis or recent history of most types of cancer.12  \nScreening for breast and prostate cancers, and delay or deferral of transplantation following any positive result, could explain the deficit of these cancers among US SOTRs, and if so, international variation in screening practice (eg, age range, screening interval) might then explain why the deficit is not seen among SOTRs in other countries. To explore whether cancer screening  \nexplains the reduced risks for breast and prostate cancers among US SOTRs, we conducted a case-control study among US adults older than age 65 years.  \nWe used data from the Surveillance, Epidemiology, and End Results (SEER)-Medicare linkage.13 , 14 SEER-Medicare links data from 22 SEER cancer registries to claims from Medicare (the federal health insurance program fo","cbCaiqD5hBKijE9R","https://ap.wps.com/l/cbCaiqD5hBKijE9R","pdf",443387,"English","# Abstract\n# Background\n# Study Rationale and Screening Hypothesis\n# Data Source: SEER-Medicare Linkage\n# Study Design and Participant Selection\n# Outcomes and Identification of Transplant Procedures","[{\"question\":\"What question does the study address about US organ transplant recipients?\",\"answer\":\"It examines whether pretransplant cancer screening explains why US solid organ transplant recipients have lower breast and prostate cancer incidence than the general population.\"},{\"question\":\"What data and timeframe were used for the case-control study?\",\"answer\":\"The study used SEER-Medicare linkage data for adults aged 65 years or older, covering diagnoses from 2000 to 2019.\"},{\"question\":\"How were screening and transplant status captured in the analysis?\",\"answer\":\"Medicare claims identified solid organ transplant procedures, and screening was determined using mammography or prostate-specific antigen testing before case/control selection.\"}]","Pretransplant screening and lower incidence of breast and prostate cancers among organ transplant recipients in the United States - Brief Communications | PDF",1790178671,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/58a9636f7ca26ca8b236f69e9146bbcf.webp",983,1291,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/24c7bd1564182bc93924455c894c7a6a.webp",982,1290,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3c18dd35753777261bf7f9d94c046e0c.webp",981,1289,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/46a5bf082f58458162c149f705394d8a.webp",980,1287]